Close

UPDATE: Short-Seller Article on Ligand (LGND) is Silly, Underlying Strength Remains - Roth Capital

Go back to UPDATE: Short-Seller Article on Ligand (LGND) is Silly, Underlying Strength Remains - Roth Capital
LIGAND PHARMA (NASDAQ: LGND) Delayed: 69.89 +1.36 (1.98%)
Previous Close $68.53    52 Week High $139.79 
Open $68.50    52 Week Low $82.07 
Day High $71.16    P/E 162.53 
Day Low $68.50    EPS $0.43 
Volume 140,672